Comparison of Efonidipine/Irbesartan combination and Irbesartan monotherapy for uncontrolled hypertensio
Phase 4
- Conditions
- Hypertension
- Registration Number
- JPRN-UMIN000002242
- Lead Sponsor
- Kyoto University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
1. pregnant patients 2. patients with severe liver dysfunction 3. patients with severe renal dysfunction 4. allergic to irbesartan or efonidipine 5. patients judged to be inappropriate for this study by attending physicians
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method blood pressure lowering after 1 month
- Secondary Outcome Measures
Name Time Method 1. blood pressure lowering after 6 months 2. Change in albuminuria after 6 months 3. adverse events